MedPath

Association Between Cancer and Sarcoidosis

Completed
Conditions
Cancer
Sarcoidosis
Registration Number
NCT03844698
Lead Sponsor
University of Miami
Brief Summary

The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
171
Inclusion Criteria
  • Clinical diagnosis of Sarcoidosis following cancer
  • Granulomatous reaction must be proven by pathology
Read More
Exclusion Criteria

. Aged younger than 18 years old.

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathology Proven Sarcoidosis In Patients with Cancerup to 10 years

Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis.

Secondary Outcome Measures
NameTimeMethod
Cancer Cytogenetics and Sarcoidosisup to 10 years

Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer.

Treatment Requirement of Sarcoidosisup to 10 years

Number of Participants With Sarcoidosis Events as Assessed by Requirement of Treatment with Steroid or Other Anti-Sarcoid Medications in Patients with Cancer.

Trial Locations

Locations (1)

University of Miami, Miller School of Medicine

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath